Evidence map›Paper›PMID 29734393›Full record

ArticlePLoS pathogens2018

Orientia tsutsugamushi uses two Ank effectors to modulate NF-κB p65 nuclear transport and inhibit NF-κB transcriptional activation.

Sean M Evans, Kyle G Rodino, Haley E Adcox, Jason A Carlyon

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 64 citations in OpenAlex.

  1. bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Transformation and allelic exchange inbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Pathogens (Basel, Switzerland) · 2026
    Article
  7. Article
  8. A Compact Closed Genome ofPathogens (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Article
  11. Identification of candidate nucleomodulins in ESKAPE bacteria -Frontiers in cellular and infection microbiology · 2026
    Article
  12. Review
  13. Bacterial Puppeteering: How the Stealth BacteriumPathogens (Basel, Switzerland) · 2025
    Review
  14. Article
  15. Article
  16. Pathogens (Basel, Switzerland) · 2025
    Article
  17. Article
  18. Review
  19. Infection and immunity · 2025
    Article
  20. Infection and immunity · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sean M EvansDepartment of Microbiology and Immunology, Virginia Commonwealth University Medical Center, School of Medicine, Richmond, Virginia, United States of America.ORCID 0000-0001-9515-4990
Kyle G RodinoDepartment of Microbiology and Immunology, Virginia Commonwealth University Medical Center, School of Medicine, Richmond, Virginia, United States of America.ORCID 0000-0001-9308-4810
Haley E AdcoxDepartment of Microbiology and Immunology, Virginia Commonwealth University Medical Center, School of Medicine, Richmond, Virginia, United States of America.
Jason A CarlyonDepartment of Microbiology and Immunology, Virginia Commonwealth University Medical Center, School of Medicine, Richmond, Virginia, United States of America.ORCID 0000-0003-2778-5066
Virginia Commonwealth University Medical Center · US

Funding

Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Kim Felder Rhoads · 1985 to 2026
$51.0M
Defining the pathobiological roles of Orientia tsutsugamushi Ank proteinsR01AI123346 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CARLYON, JASON A · 2017 to 2020
$1.5M
Defining the pathobiological roles of Orientia tsutsugamushi Ank proteinsR56AI123346 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CARLYON, JASON A · 2016 to 2021
$833k
NCI NIH HHS P30 CA016059NIAID NIH HHS R01 AI123346NIAID NIH HHS R56 AI123346NIH HHS R01-AI123346-01A1NIH HHS R56 AI123346-01
6 · The paper itself

Abstract

Orientia tsutsugamushi causes scrub typhus, a potentially fatal infection that threatens over one billion people. Nuclear translocation of the transcription factor, NF-κB, is the central initiating cellular event in the antimicrobial response. Here, we report that NF-κB p65 nuclear accumulation and NF-κB-dependent transcription are inhibited in O. tsutsugamushi infected HeLa cells and/or primary macrophages, even in the presence of TNFα. The bacterium modulates p65 subcellular localization by neither degrading it nor inhibiting IκBα degradation. Rather, it exploits host exportin 1 to mediate p65 nuclear export, as this phenomenon is leptomycin B-sensitive. O. tsutsugamushi antagonizes NF-κB-activated transcription even when exportin 1 is inhibited and NF-κB consequently remains in the nucleus. Two ankyrin repeat-containing effectors (Anks), Ank1 and Ank6, each of which possess a C-terminal F-box and exhibit 58.5% amino acid identity, are linked to the pathogen's ability to modulate NF-κB. When ectopically expressed, both translocate to the nucleus, abrogate NF-κB-activated transcription in an exportin 1-independent manner, and pronouncedly reduce TNFα-induced p65 nuclear levels by exportin 1-dependent means. Flag-tagged Ank 1 and Ank6 co-immunoprecipitate p65 and exportin 1. Both also bind importin β1, a host protein that is essential for the classical nuclear import pathway. Importazole, which blocks importin β1 activity, abrogates Ank1 and Ank6 nuclear translocation. The Ank1 and Ank6 regions that bind importin β1 also mediate their transport into the nucleus. Yet, these regions are distinct from those that bind p65/exportin 1. The Ank1 and Ank6 F-box and the region that lies between it and the ankyrin repeat domain are essential for blocking p65 nuclear accumulation. These data reveal a novel mechanism by which O. tsutsugamushi modulates the activity and nuclear transport of NF-κB p65 and identify the first microbial proteins that co-opt both importin β1 and exportin 1 to antagonize a critical arm of the antimicrobial response.

Indexed as

Active Transport, Cell NucleusAnkyrin RepeatBacterial Proteinsbeta KaryopherinsExportin 1 ProteinHeLa CellsHost-Pathogen InteractionsHumansKaryopherinsNF-kappa BNF-KappaB Inhibitor alphaOrientia tsutsugamushiReceptors, Cytoplasmic and NuclearScrub TyphusTranscriptional ActivationTranscription Factor RelABacterial Proteinsbeta KaryopherinsExportin 1 ProteinKaryopherinsKPNB1 protein, humanNF-kappa BNF-KappaB Inhibitor alphaReceptors, Cytoplasmic and NuclearRELA protein, humanTranscription Factor RelA

Identifiers

PMID29734393
PMCPMC5957444
OpenAlexW2800567329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.